相关实验视频
Updated: Feb 26, 2026

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
114.0K
细胞启动因子6通过整蛋白-FAK信号轴调节小细胞肺癌的可塑性
Haoning Peng1,2,3, Zhile Wang1,2, Mengyao Wang1
1Institute of Thoracic Oncology, Frontiers Science Center for Disease-related Molecular Network, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
Nature communications
|February 24, 2026
概括
翻译因子eIF6驱动小细胞肺癌 (SCLC) 的非神经内分泌状态,促进化疗耐药性. 准eIF6可能会恢复SCLC对基治疗的敏感性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有攻击性的癌症,以基化疗耐药性快速发展而闻名.
- SCLC表现出可塑性,在神经内分泌 (NE) 和非神经内分泌 (非NE) 状态之间切换,这与治疗失败有关.
- 基础上SCLC可塑性和耐药性的机制仍然不太清楚.
研究的目的:
- 调查翻译启动因子eIF6在调节SCLC中非NE转分化的作用.
- 阐明eIF6影响SCLC可塑性和化疗敏感性的分子机制.
- 确定eIF6-CD104-FAK轴作为克服SCLC耐药性的潜在治疗点.
主要方法:
- 在SCLC细胞系,小鼠模型和患者样本中分析eIF6表达.
- 研究eIF6与核糖体和CD104-FAK复合物的相互作用.
- 评估eIF6调制对非NE转差和MAPK通路激活的影响.
- 在体外和体内评估eIF6抑制对SCLC化疗敏感性的影响.
主要成果:
- 在非NESCLC州,eIF6表达显著上调.
- eIF6与核糖体分离并与CD104-FAK复合体相互作用,激活MAPK通路.
- 抑制eIF6抑制非NE转基因差异化,并在SCLC模型中增强化疗敏感性.
- eIF6-CD104-FAK轴被确定为SCLC可塑性和抗性的关键调节器.
结论:
- eIF6是SCLC中非NE转差和化疗耐药性的关键调节者.
- eIF6-CD104-FAK信号通路代表了SCLC治疗的新型治疗标.
- 针对eIF6提供了一种潜在的策略,以克服小细胞肺癌中的抗性.
相关概念视频
Intracellular Signaling Affects Focal Adhesions
3.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.7K
Activation of Integrins
5.3K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.3K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.7K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.7K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Regulation of Angiogenesis and Blood Supply
3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K

